Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. [electronic resource]
Producer: 20120619Description: 455-60 p. digitalISSN:- 1096-8652
- Aged
- Aged, 80 and over
- Amino Acids -- urine
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Biomarkers
- Bone Remodeling -- drug effects
- Creatinine -- blood
- Cross-Over Studies
- Curcumin -- administration & dosage
- Disease Progression
- Double-Blind Method
- Female
- Humans
- Immunoglobulin Light Chains -- analysis
- Male
- Middle Aged
- Monoclonal Gammopathy of Undetermined Significance -- blood
- Multiple Myeloma -- prevention & control
- Myeloma Proteins -- analysis
- Parathyroid Hormone -- blood
- Treatment Outcome
- Vitamin D -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.